Invacare Corp. (IVC) Reports In-Line Q3 EPS, Updates FY11 Guidance
Invacare Corp. (
Invacare Corp. sees FY2011 EPS of $2.05-$2.10, versus prior guidance of $2.05-$2.15 and the consensus of $2.08. The Company also is adjusting its 2011 guidance on organic net sales growth to between 2.5% and 3.0% from its previously announced guidance of 3.5% to 4.5%, and on free cash flow to between $80 and $90 million from its previously announced guidance of $85 million to $95 million.
NYSE: IVC) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $456.5 million versus the consensus estimate of $451.15 million.
Invacare Corp. sees FY2011 EPS of $2.05-$2.10, versus prior guidance of $2.05-$2.15 and the consensus of $2.08. The Company also is adjusting its 2011 guidance on organic net sales growth to between 2.5% and 3.0% from its previously announced guidance of 3.5% to 4.5%, and on free cash flow to between $80 and $90 million from its previously announced guidance of $85 million to $95 million.